02017nas a2200205 4500000000100000008004100001100001600042700001400058700002000072700001400092700001600106700001700122700001600139245009400155856005500249300000900304490000700313520147700320022001401797 2016 d1 aPetersen EE1 aStaples E1 aMeaney-Delman D1 aFischer M1 aEllington S1 aCallaghan WM1 aJamieson DJ00aInterim guidelines for pregnant women during a Zika virus outbreak - United States, 2016. uhttp://www.cdc.gov/mmwr/volumes/65/wr/mm6502e1.htm a30-30 v653 a
CDC has developed interim guidelines for health care providers in the United States caring for pregnant women during a Zika virus outbreak. These guidelines include recommendations for pregnant women considering travel to an area with Zika virus transmission and recommendations for screening, testing, and management of pregnant returning travelers. Updates on areas with ongoing Zika virus transmission are available online (http://wwwnc.cdc.gov/travel/notices/). Health care providers should ask all pregnant women about recent travel. Pregnant women with a history of travel to an area with Zika virus transmission and who report two or more symptoms consistent with Zika virus disease (acute onset of fever, maculopapular rash, arthralgia, or conjunctivitis) during or within 2 weeks of travel, or who have ultrasound findings of fetal microcephaly or intracranial calcifications, should be tested for Zika virus infection in consultation with their state or local health department. Testing is not indicated for women without a travel history to an area with Zika virus transmission. In pregnant women with laboratory evidence of Zika virus infection, serial ultrasound examination should be considered to monitor fetal growth and anatomy and referral to a maternal-fetal medicine or infectious disease specialist with expertise in pregnancy management is recommended. There is no specific antiviral treatment for Zika virus; supportive care is recommended.
a1545-861X